Trademark Attorney / Law Firm

STEPHEN BEAN – Trademark Portfolio

STEPHEN BEAN specializes in Class 44 (Medical Services) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 2 total filings concentrated in this category. The practice also covers Class 5 (Pharmaceuticals) along with 2 other Nice Classification classes. Filing activity spans from 2021 to 2025. Currently, 0 trademarks are registered and 1 is pending.

2 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

DR. VIP
DR. VIP
Pending 2025
LONGITY
LONGITY
Cancelled 2021

Practice Areas by Trademark Class

STEPHEN BEAN's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademark applications has STEPHEN BEAN filed?

STEPHEN BEAN has filed 2 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 pending, 1 cancelled.

What trademark classes does STEPHEN BEAN specialize in?

STEPHEN BEAN has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

How long has STEPHEN BEAN been filing trademarks?

STEPHEN BEAN's trademark filing history with the USPTO spans from 2021 to 2025, covering 4 years of trademark practice. During this period, STEPHEN BEAN has handled 2 trademark applications.

What is STEPHEN BEAN's trademark registration success rate?

STEPHEN BEAN has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.